Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Johnson & Johnson is a global healthcare leader focused on the research, development, and manufacturing of innovative medicines and medical technologies. Following the 2023 spin-off of its consumer health division, the company operates through two primary segments: Innovative Medicine and MedTech. The Innovative Medicine segment, formerly known as Janssen, targets high-need areas such as oncology, immunology, neuroscience, and cardiovascular diseases. The MedTech segment provides advanced solutions in surgery, orthopedics, and vision. Headquartered in New Brunswick, New Jersey, the company maintains a massive global footprint and a robust R&D pipeline aimed at addressing some of the world's most complex health challenges.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Johnson.